Glaucoma is a multifactorial neurodegenerative ocular disease leading to progressive loss of retinal ganglion cells and their axons that form the optic nerve, causing blindness. Knowledge of the pathogenesis and development of equine glaucoma is in its infancy compared with human glaucoma. Glaucoma occurs most commonly secondary to uveitis and may be underdiagnosed or misdiagnosed in horses suffering from uveitis. Recognition and clinical diagnosis of glaucoma in the horse is improved with clinician awareness and the availability of handheld tonometers. Therapy for glaucoma is aimed at decreasing aqueous humor production through medical and surgical means. Even with therapy, long-term prognosis for vision is poor.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cveq.2017.07.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sub-Tenon's anesthesia in equine cataract surgery and vitrectomy: a retrospective case series (2018-2022).
Schweiz Arch Tierheilkd
November 2024
Pferdeklinik Tillysburg, Sankt Florin, Austria.
A retrospective data analysis was performed on 17 eyes from 13 horses which underwent a sub-Tenon's injection to facilitate phacoemulsification or pars plana vitrectomy under general anesthesia between 2018 and 2022. All procedures were performed by the same veterinary ophthalmologist. Seven eyes received a sub-Tenon's dose of 7 ml lidocaine (XylocainÒ, 2 % lidocaine hydrochloride, Germany, Aspen Germany GmbH), and 10 eyes received 7 ml mepivacaine (MepinaestÒ purum 2 %, mepivacaine hydrochloride, Switzerland, Gebro Pharma GmbH).
View Article and Find Full Text PDFClinical characteristics and visual outcomes of animal-induced ocular injuries: a prospective multicenter study in Iran.
Front Med (Lausanne)
September 2024
Geriatric Ophthalmology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Background: Animal-induced ocular injuries represent an under-documented health problem that may pose significant visual complications. This study aimed to investigate the clinical characteristics and outcomes of ocular injuries caused by animals.
Methods: This multicenter prospective study enrolled patients with a history of animal-induced ocular injuries presenting to the ophthalmology departments of two tertiary hospitals over a one-year period.
The effect of systemic acetazolamide administration on intraocular pressure in healthy horses-A preliminary study.
Vet Ophthalmol
June 2024
Koret School of Veterinary Medicine (KSVM), The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
Objectives: In equine glaucoma, topical treatment with carbonic anhydrase inhibitors (CAIs) is recommended. Oral acetazolamide, a systemic CAI, is used in horses with hyperkalemic periodic paralysis. Information regarding its effect on equine intraocular pressure (IOP) is scarce.
View Article and Find Full Text PDFExtensive intraocular melanoma with secondary glaucoma in a 15-month-old Thoroughbred filly.
Vet Med Sci
May 2024
Department of Rossdales Laboratories, Rossdales Equine Hospital and Diagnositc Centre, Newmarket, UK.
Article Synopsis
- A 15-month-old Thoroughbred filly was diagnosed with glaucoma in the right eye, which was linked to a mass in the anterior chamber causing corneal edema and blepharospasm.
- Following treatment for the secondary glaucoma, the mass was identified as a likely intraocular melanoma, leading to an enucleation procedure.
- Histopathological analysis confirmed it as a unique case of invasive uveal melanoma, highlighting the importance of considering this diagnosis in glaucoma cases in young horses.
Equine uveitis: Outcome and adverse effects after one or two intravitreal low-dose gentamicin injections.
Equine Vet J
January 2025
Equine Clinic, University Animal Hospital, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Background: Uveitis is common in horses, potentially turning chronic (persistent or recurrent) resulting in impaired vision or blindness. All mainstay therapeutics aims at controlling inflammation, but long-term or lifelong treatment is often needed with possibly severe side effects. Therefore, intravitreal injections with low-dose gentamicin (IVGI) have been used in attempt to give a long-lasting result with potentially less side effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!